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ABSTRACT
A variety of DNA lesions, secondary DNA struc-
tures or topological stress within the DNA template
may lead to stalling of the replication fork. Recov-
ery of such forks is essential for the maintenance of
genomic stability. The structure-specific endonucle-
ase Mus81–Mms4 has been implicated in processing
DNA intermediates that arise from collapsed forks
and homologous recombination. According to pre-
vious genetic studies, the Srs2 helicase may play a
role in the repair of double-strand breaks and ssDNA
gaps together with Mus81–Mms4. In this study, we
show that the Srs2 and Mus81–Mms4 proteins phys-
ically interact in vitro and in vivo and we map the
interaction domains within the Srs2 and Mus81 pro-
teins. Further, we show that Srs2 plays a dual role in
the stimulation of the Mus81–Mms4 nuclease activ-
ity on a variety of DNA substrates. First, Srs2 directly
stimulates Mus81–Mms4 nuclease activity indepen-
dent of its helicase activity. Second, Srs2 removes
Rad51 from DNA to allow access of Mus81–Mms4
to cleave DNA. Concomitantly, Mus81–Mms4 inhibits
the helicase activity of Srs2. Taken together, our data
point to a coordinated role of Mus81–Mms4 and Srs2
in processing of recombination as well as replication
intermediates.
INTRODUCTION
Homologous recombination (HR) is responsible for the re-
pair of DNA double-strand breaks (DSBs), single-stranded
DNA gaps, shortened telomeres and stalled or collapsed
replication forks. HR repair is characterized by the assem-
bly of the Rad51 protein on single-stranded DNA to form
the so-called presynaptic filament. These nucleoprotein fila-
ments search for homology and mediate the invasion of the
sister chromatid resulting in the formation of joint DNA
molecules called D-loops (1,2). After D-loop formation, re-
pair can proceed by two alternative pathways. In classical
double-strand break repair (DSBR), the D-loop is stabi-
lized by capture of the second end of theDSBwhich leads to
the generation of a double-Holliday Junction (dHJ). In the
alternative pathway, synthesis-dependent strand-annealing
(SDSA), the invading strand is extended by DNA poly-
merase but then displaced from the D-loop and annealing
with the second end of the DSB (Figure 8 (2,3)).
Numerous proteins have been implicated in HR. Among
them, the Srs2 protein stands out with its multiple roles dur-
ing this process (4). It is a 3′–5′ DNAhelicase (5,6) related to
the bacterial UvrDprotein (7). Apart from the ability to dis-
mantle Rad51 filament and thereby inhibit HR (8,9), Srs2
appears to promote the SDSA pathway (10,11) by facilitat-
ing displacement of Rad51 from non-invading ssDNA end
or by regulating elongation of the invading strand during
HR to prevent second-end capture (12). Srs2 is also directly
involved in both branches of post replication repair (PRR),
where it could play an important role in the decision be-
tween error-free or error-prone pathways (13–15). It is also
required for proper checkpoint activation, as well as recov-
ery and adaptation in response to cell cycle arrest (16,17).
Many synthetic-lethal interactions with Srs2 result in accu-
mulation of toxic recombination intermediates (18–21).
Mus81 has been implicated in processing various repli-
cation and recombination intermediates. It is a structure-
selective endonuclease that shares homology with the
XPF/Rad1 family of proteins. Members of this family
usually form a heterodimeric complex with partner pro-
teins (22). While the Saccharomyces cerevisiae partner pro-
tein for Mus81 has been identified as Mms4, in fission
yeast and mammalian cells, Eme1 forms a complex with
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Mus81 with similar activities to those of its budding
yeast counterpart (23,24). Biochemical studies have demon-
strated that Mus81–Mms4 has preferences for a num-
ber of DNA structures, such as nicked HJs, D-loops, 3′-
flaps and forks (24–27). However, it still remains unclear
whether Holliday junctions (HJs), the central intermedi-
ates in the HR process, are direct physiological substrates
for the Mus81–Mms4 (Eme1) complex (25,27–28). In ad-
dition, mus81/mms4/eme1 mutants are hypersensitive to a
range of agents includingmethyl methanesulfonate (MMS),
camptothecin (CPT), hydroxyurea (HU) andUV light, sug-
gesting a role for this complex in processing aberrant DNA
junctions formed at stalled replication forks (29–32). Both
budding and fission yeast mus81/mms4/eme1 mutants re-
duce or eliminate meiotic recombination indicating a role in
processing intermediates during meiosis (32,33). Similarly
to Srs2, deletion of Mus81 was shown to be synthetically
lethal with mutation in SGS1 and this lethality can be sup-
pressed by elimination of HR (18,32,34).
In this study, we show that the S. cerevisiae proteins,
Srs2 and Mus81–Mms4 directly associate in vitro and fre-
quently co-localize in vivo. We mapped the interaction do-
mains within the Srs2 and Mus81 proteins and found that
the interaction leads to a dramatic stimulation of Mus81–
Mms4 nuclease activity. This stimulation is independent of
the Srs2’s helicase/ATPase activity and its SUMO/PCNA
interaction domain. In addition, Srs2 relieves the inhibi-
tion of Mus81–Mms4 nuclease activity by Rad51, but in an
ATPase-dependent manner. At the cellular level, the func-
tional interaction between Srs2 and Mus81 is supported
by their co-localization at damage-induced foci. Taken to-
gether, the stimulation of Mus81–Mms4 nuclease activity
by Srs2 might be required not only for processing classical
recombination intermediates but also for the rescue of ar-
rested forks.
MATERIALS AND METHODS
Yeast strains and plasmids
Standard procedures for yeast mating, sporulation, dis-
section, transformation and preparation of growth media
(35,36) were used to obtain strains for this study (Supple-
mentary Table S1). All yeast strains used are derivatives
of W1588–4C (MATa ade2–1 can1–100 ura3–1 his3–11, 15
leu2–3,112 trp1–1) (37) a RAD5 derivative of W303–1A
(38).
Plasmids used in this study are described in Supplemen-
tary Table S2. Oligonucleotides used for construction are
listed in Supplementary Table S3. The Srs2783–1174::pGEX-
6P-1 fragment was amplified by PCR and cloned into
the EcoRI site of pGEX-6P-1.Srs2783–998::pGEX-6P-1 and
Srs2783–898::pGEX-6P-1 were created by site-directed mu-
tagenesis of Srs2783–1174::pGEX-6P-1 by producing stop
codons at corresponding positions. Fragment Srs2898–998
was amplified by polymerase chain reaction (PCR) and
cloned into the EcoRI site of pGEX-6P-1. Construction
of Srs2998–1174 fragment in pGEX-6P-1 was described ear-
lier (12). The N-terminal truncation of Srs2 1–700::pET11c
was made by site-directed mutagenesis of Srs2::pET11c
by adding stop codon at corresponding positions. Plas-
mid pKR6317 was constructed by amplifying the first
319aa of Mus81 on an NdeI-NotI PCR fragment using
oligos 462 (GAACATATGGAACTCTCATCAAACTTA)
and 924 (TTTGCGGCCGCCTACTGTTTGATCATCA
GA) and ligating it together with an 88-bp NotI-BamHI
linker into the NdeI-BamHI sites of pET11a. This con-
struct expresses amino acids 1–319 of Mus81 fused to
a 26aa C-terminal V5-His6 epitope tag. The Mus811–319
fragment was cloned as a NdeI/BamHI fragment from
Mus811–319::pET11a into the pGBKT7 yeast two-hybrid
vector. Plasmids containing Mus811–245, Mus811–220 and
Mus811–155 fragments in two-hybrid vectors were gener-
ated by site-directed mutagenesis to incorporate appropri-
ate stop codons. The plasmid for GAL inducible expression
of Mre11 protein contains the Mre11 open reading frame
(ORF) amplified by PCR and cloned into BamHI site of
pPM271 vector.
Expression and purification of Srs2 and its variants
Wild-type Srs2, Srs2-K41R and Srs21–860 were expressed
and purified as previously described (39,40). Another N-
terminal truncation of Srs2 (Srs21–898) was purified as de-
scribed (41). Srs21–700 was expressed in Arctic RIL cells
and purified the same way as previously described for
wild-type Srs2. The C-terminal truncations of Srs2 corre-
sponding to Srs2783–1174, Srs2783–998, Srs2783–898, Srs2898–998
and Srs2998–1174 were cloned in the pGEX-6P-1 vector and
expressed in Escherichia coli BL21(DE3) cells by induc-
tion with 0.1 mM isopropyl-1-thio--D-galactopyranoside
(IPTG) overnight at 16◦C.After harvesting cells by centrifu-
gation, the cell pellets were resuspended and sonicated in
cell-breakage buffer (CBB) (50 mM Tris pH 7.5, 10% su-
crose, 10 mM EDTA, 1 mM DTT and 0.01% NP40) con-
taining 150mMKCl and protease inhibitors (2g/ml apro-
tinin, 5 g/ml benzamidine, 10 M chymostatin, 10 M
leupeptin and 1 M pepstatin A). The crude extract was
clarified by ultracentrifugation (100 000 x g, 4◦C, 1 h) and
the supernatant loaded on SP-Sepharose (7 ml, GEHealth-
care). The column was eluted with 70 ml of 150–1000 mM
KCl in buffer K (20 mM K2HPO4, 10% glycerol, 0.5 mM
EDTA). Fractions containing Srs2 were mixed for 1 h at
4◦C with 500 l of GSH-Sepharose (GE Healthcare) and
washed in buffer K containing 100 mM KCl. Bound pro-
teins were washed with 5 ml of 100mMKCl in buffer K and
eluted in steps with 500 l of 10, 50, 100 and 200 mM glu-
tathione (GSH) in buffer K containing 100 mM KCl. The
peak fractions, eluting in the range of 20–100 mM GSH,
were loaded onto a 1 ml MonoS column (GE Healthcare)
and eluted with a 10 ml gradient from 150 to 1000 mM
KCl in buffer K. Fragments of Srs2 were concentrated and
stored in 5 l aliquots at −80◦C.
Purification of yeast and human Mus81 protein and its com-
plexes
Yeast Mus81–Mms4 and Mus81 proteins as well as hu-
man MUS81–EME1 complex were expressed in E. coli
and purified as previously described (42). For expression
of Mus811–319, 10 g of E. coli cell paste was sonicated in
50 ml CBB buffer containing 150 mM KCl and clarified as
described above. The supernatant was passed through Q-
Sepharose (7 ml) and the flow-through fraction was then
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directly applied to SP-Sepharose (7 ml) and eluted with a
70 ml gradient of 150–1000 mMKCl in buffer K. Fractions
containing Mus811–319 were then mixed with His-Select Ni
affinity gel (Qiagen) for 1 h at 4◦C. The bound protein was
eluted in steps with 500l each of 150, 300 and 500mM im-
idazole in buffer K containing 150 mMKCl. The peak frac-
tion was loaded on a 1 ml MonoS column (GE Healthcare)
and eluted with a 10 ml gradient of 150–1000 mM KCl in
bufferK.Nearly homogenousMus811–319 was concentrated
and stored in 5 l aliquots at −80◦C.
Expression and purification of other proteins
The Rad1–Rad10 complex was expressed in E. coli strain
Rosetta(DE3)pLysS from a bicistronic plasmid containing
both 6xHis-Rad1 and Rad10 (32). The overexpression was
induced at OD600 ∼ 0.8 by addition of 0.1 mM IPTG fol-
lowed by an incubation at 16◦C overnight. The cells were
pelleted and stored at −80◦C. Extract from 9 g of cell paste
was prepared by sonication in 40 ml of CBB buffer. The
lysate was clarified by ultracentrifugation (100 000 x g, 4◦C,
1 h) and the supernatant was incubated with 1 ml of HIS-
Select nickel affinity gel (Sigma) for 1 h at 4◦C. The beads
were washed with 12 ml of buffer K containing 150 mM
KCl. The bound proteins were eluted with buffer K supple-
mentedwith 50mMKCl and containing 50, 150, 300, 500 or
1000mM imidazole. The fractions containing Rad1–Rad10
complex (from 150 to 500 mM imidazole) were pooled and
applied onto a 1 ml Heparin column followed by elution
using an 8 ml gradient of 275–1000 mM KCl in buffer K.
The peak fractions of Rad1–Rad10 complex eluting from
the Heparin column at ∼500 mMKCl were pooled, loaded
onto a 0.5 ml MonoQ column and eluted using a 5 ml gra-
dient of 275–1000 mM KCl in buffer K. The fractions con-
taining eluted Rad1–Rad10 complex were concentrated to
400 l in a VivaSpin-2 concentrator, and then fractionated
in a 23 ml Sephacryl S400 column in K buffer containing
300 mM KCl. The peak fractions of Rad1–Rad10 complex
were concentrated to 2 g/l and stored in small aliquots
at −80◦C.
The expression of Mre11 was described previously (43).
Briefly, overnight cultures grown at 30◦C incomplete syn-
thetic media lacking uracil were diluted 8-fold into fresh
medium containing galactose and incubated at 30◦C for 24
h to induce the expression of Mre11. After harvesting, the
cells were lysed with cryo-mill (LABTECH) and yeast pow-
der was resuspended in 100 ml of CBB buffer containing
100 mM KCl and subjected to ammonium sulfate precipi-
tation at 0.28 g/ml. The precipitate was dissolved in 100 ml
of buffer K with protease inhibitors and passed through Q-
Sepharose (20 ml).Mre11 was eluted with a 200 ml gradient
of 100–1000 mMKCl in K buffer and then loaded onto a 1
ml hydroxyapatite column and eluted with a 10 ml gradient
of 0–400 mM KH2PO4 in buffer K. Fractions containing
Mre11 were loaded on a 1 ml MonoS and eluted with a 10
ml gradient of 100–1000 mM KCl in buffer K. The peak
fractions containing Mre11 were concentrated and stored
at −80◦C.
Yeast Rad51was expressed and purified as described else-
where (6).
DNA substrates
Oligonucleotides were purchased from VBC Biotech. Se-
quences of oligonucleotides used for synthetic substrates
are shown in Supplementary Table S4. The individual
substrates were prepared by annealing of corresponding
oligonucleotides as previously described (41).
Nuclease assay
Nuclease assays withMus81–Mms4 were performed as pre-
viously described (42). Briefly,Mus81–Mms4 (0.25 nM)was
pre-incubated with Srs2, Srs2-K41R or various truncation
proteins (5, 10, 20, 40 and 80 nM) at 30◦C for 30 min in
20 l of buffer N (20 mM Tris, pH 8.0, 100 mM NaCl, 100
g/ml bovine serum albumin, 0.2 mM dithiothreitol, 5%
glycerol and 10 mM MgCl2). DNA (7 nM) was added to
the reaction mixtures and incubated for another 30 min at
37◦C. After deproteinization by incubation with 0.1% SDS
and 500 g/ml of proteinase K at 37◦C for 5 min, reactions
were resolved on 10%polyacrylamide gels and scannedwith
a Fuji FLA 9000 imager (Fuji). In some cases the prod-
ucts were also analyzed on 13% denaturing gel. The exper-
iments were done in triplicates and the gels were quantified
by Multi Gauge V3.2 software (Fuji).
In the time course experiment, the indicated amount of
Mus81–Mms4 was incubated with 10 nM of Srs2 for 30
min. After addition of fluorescently labeled DNA (7 nM),
reaction mixtures were incubated for 10, 20, 30, 40 and 50
min and analyzed as described above. In the targeting as-
say, Srs2 (70 nM) was first pre-incubated with the 3′-flap
structure (6 nM) at 30◦C for 10 min followed by addition
of Mus81–Mms4 (0.25 nM) and incubation for 2.5, 5, 7.5,
10 and 15 min at 30◦C. Corresponding aliquots were ana-
lyzed on a 10% native gel as described above. In the reaction
containing humanMUS81–EME1 protein, Srs2 (10, 20 and
40 nM) was mixed with 0.25 nM MUS81–EME1 and the
reaction was performed as described above. For the Rad1–
Rad10 reaction, 0.2 nMof Rad1–Rad10 wasmixed with 10,
20, 40, 80, 150 and 300 nM Srs2783–898 together with Y form
DNA substrate (7 nM) and the reaction was carried out as
described above.
Rad51 removal assay
In the nuclease assay containing Rad51, increasing concen-
trations of Rad51 (100, 200, 400, 600 and 800 nM)were pre-
incubated with DNA (7 nM) in 20 l of buffer N and 800
nM ATP for 10 min at 37◦C, then Mus81–Mms4 (0.4 nM)
was added to the mixture and the reaction was carried out
as above. Next, yeast Rad51 (600 nM) was pre-incubated
with DNA (7 nM) for 10 min at 37◦C followed by addition
ofMus81–Mms4 (0.4 nM) together with increasing concen-
trations of Srs2 or Srs2-K41R mutant (5, 7.5, 10, 15 and 20
nM) and incubated for 30 min at 37◦C. After deproteiniza-
tion, the reactions were resolved on 10% native PAGE and
scanned with a Fuji FLA 9000 imager and analyzed.
Pull-down assays
To analyze the interaction betweenMus81–Mms4 and Srs2,
yeast Mus81–Mms4 complex, Mus81 or Mus811–319 (5
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g each) were pre-incubated with 5 g of various GST-
tagged Srs2 fragments (Srs2783–1174, Srs2783–998, Srs2783–898,
Srs2898–998 or Srs2998–1174) for 1 h at 4◦C. After pre-
incubation, 10 l of GSH-Sepharose 4 Fast Flow (GE
Healthcare) in 25 l of buffer K containing 150 mM KCl
was added and reactions were incubated for an additional
30 min at 4◦C. Supernatants were collected and beads were
washed three times with 100 l of the same buffer. The
supernatant and beads were treated with Laemmli buffer
and analyzed by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) on a 10% gel followed by
Coomassie blue staining or western blot analysis with ap-
propriate antibodies. For the pull-down using the V5 epi-
tope, the same concentrations of Srs2 as well as Srs21–700,
Srs21–898 or Srs21–860 were pre-incubated for 1 h at 4◦C with
Mus81 or Mus811–319. Anti-V5 agarose beads (10 l in 25
l of buffer K containing 200 mM KCl) were added and
reactions were incubated for 30 min at 4◦C. After incuba-
tion, the mixtures were treated as described above. Samples
were also analyzed by western blot with antibodies against
the His affinity tag present at the N-terminus of each Srs2
fragments.
The IP was performed as follows: the plasmid carrying
MUS81 gene was expressed in yeast and grown in YPD at
30◦C overnight to OD600 ∼ 1. The frozen pellet was lysed
with Immunoprecipitation (IP) buffer (50 mMTris-HCl pH
7.4, 150 mM NaCl, 0.5% Triton X-100, 1 mM PMSF, 5
g/l leupeptin and 1 g/l aprotinin) and yeast extract
containingwtMus81was incubatedwith purified Srs2783–998
and 10 l of Glutathione Sepharose 4 Fast Flow beads for
3 h at 4◦C. After incubation, supernatants and beads were
analyzed by western blot with anti-His antibodies.
Yeast two-hybrid analysis
Two-hybrid analysis was performed as described pre-
viously (44). Yeast strains PJ69–4a carrying pGADT7-
Srs2783–1174 and PJ69–4 carrying various truncations of
Mus81 (Mus811–155, Mus811–220, Mus811–245, Mus811–288,
Mus81138–632 andMus81290–632) cloned into pGBKT7 (Sup-
plementary Table S2) were mated overnight on a YPD plate
to form diploids. Thereafter, the diploid strains were se-
lected on media lacking leucine and tryptophan and grown
for 48 h at 30◦C. Cells were spotted as 10-fold serial dilu-
tions onmedium lacking leucine and tryptophan or leucine,
tryptophan and histidine and a picture was taken 3 days af-
ter incubation at 30◦C. The empty vector (pGADT7) was
included as negative control.
Helicase assays
The helicase assays with Srs2 were performed as previously
described by Marini 2012 (41). Reaction mixtures contain-
ing Srs2 (10 nM) were pre-incubated with increasing con-
centrations ofMus81–Mms4 (12.5, 25, 50, 100, 200 and 300
nM),Mus81 (12.5, 25, 50 and 100 nM) orMus811–319 (12.5,
25, 50 and 100 nM) in buffer H (30 mM Tris pH 7.5, 1 mM
DTT, 0.1 mg/ml BSA, 100 mMKCl, 20 mM creatine phos-
phate, 20 g/ml creatine kinase, 2.4 mMMgCl2 and 2 mM
ATP) for 10 min on ice. The reactions with Mre11 included
12.5, 25, 50, 100, 200, 300 and 400 nM of protein. Then, 3
nM of 3′ overhang DNA was added to the reactions and
incubated for 10 min at 30◦C. After deproteinization, by in-
cubation with 0.1% SDS and 500 g/ml of proteinase K
at 30◦C for 3 min, reactions were resolved by 12% native
PAGE and the gel was scanned with a Fuji FLA 9000 im-
ager (Fuji).
Sensitivity spot assay
Cells were grown to mid- to late-log phase in YPD and
diluted in water to OD600 ∼ 0.2. Several 10-fold serial di-
lutions were spotted on a YPD plate supplemented with
CPT (0.5, 1 and 2 g/ml), HU (25, 50 and 100 mM), MMS
(0.005, 0.01 and 0.02%) or Zeocin (2.5 and 5 g/ml). Drugs
were added to the agar medium just before pouring the
plates. Pictures of the plates were taken after 2 days incu-
bation at 30◦C.
Fluorescent microscopy
Yeast cells were grown and processed for fluorescence mi-
croscopy as described previously (45) and imaged at 25◦C.
Fluorophores were visualized on a DeltaVisionElite mi-
croscope (Applied Precision, Inc) equipped with a 100x
objective lens (Olympus U-PLAN S-APO, NA 1.4), a
cooled Evolve 512 EMCCD camera (Photometrics, Japan),
and Insight solid state illumination source (Applied Preci-
sion, Inc). Pictures were processed with Volocity software
(PerkinElmer). Images were acquired using softWoRx (Ap-
plied Precision, Inc) software.
RESULTS
Residues 783–860 of Srs2 interact with Mus81
Genetic studies in yeast have previously implicated Srs2
and Mus81 in the repair of single-stranded gaps, where
Srs2 channels the intermediate into theMus81 sub-pathway
(18,46). In order to ascertain a sub-pathway of repair that
is dependent on the activities of both Srs2 and Mus81, we
tested for a direct interaction between Srs2 andMus81 using
pull-down assays with a purified Srs2 (His-Srs21–1174) and
V5-His-Mus81. When applied to anti-V5 agarose beads,
Mus81 was able to retain full-length Srs2 (Figure 1C, lanes
1–4). Next, we also tested whether Srs2 could co-precipitate
Mus81 from yeast. Extract from yeast cells expressing His-
Mus81 was incubated in the presence or absence of purified
GST-Srs2783–998 followed by pull-down using GSH-beads.
Immunoblotting of the supernatant as well as the elution
fractions with anti-His antibody confirmed the ability of
Srs2 to bind Mus81 (Figure 1D).
In order to map the Mus81 interaction domain within
Srs2, we constructed and purified several N-terminal Srs2
truncations (Figure 1B). To test the interactionwithMus81,
we mixed two truncations (Srs21–898 or Srs21–860) with V5-
His-Mus81 and anti-V5 agarose beads. Both Srs2 variants
were retained on the beads (Figure 1C), suggesting that the
last 300 amino acids, including PCNA and Rad51 binding
domains are not necessary for the interaction with Mus81
protein. In addition, this experiment confirmed that the in-
teraction is independent of the GST-tag. To further narrow
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Figure 1. Srs2 physically interacts withMus81 andMus81–Mms4. (A) Schematic illustration of the domains within Srs2. (B)Purified Srs2 (lane 1), Srs21–898
(lane 2), Srs21–860 (lane 3), GST-Srs2783–1174 (lane 4), GST-Srs2783–998 (lane 5), GST-Srs2783–898 (lane 6), GST-Srs2898–998 (lane 7) and Srs21–700 (lane 8)
used in the study were resolved by SDS-PAGE and stained with Coomassie blue. (C) Full-length Srs2 (5 g, lanes 1–4), Srs21–898 (lanes 5–8) and Srs21–860
(lanes 10–13) were incubated with anti-V5 agarose beads either alone or in the presence of Mus81 (5 g). The beads were incubated, washed and treated
with SDS to elute bound proteins. The supernatant (S) and eluate (E) fractions were analyzed by Coomassie blue staining. The asterisk shows protein
contamination. (D) Yeast extract containing His-Mus81 was incubated with GSH-beads alone (lanes 1 and 2) or with purified GST-Srs2783–998 (lanes 3
and 4). After incubation, supernatants and beads were analyzed by western blot with anti-His antibodies to detect the presence of Mus81 protein. (E)
Mus81 (5 g) was mixed with GSH-beads either in the absence (lanes 1 and 2) or presence of the indicated GST fragments of Srs2 (5 g; lanes 3–10). The
products were analyzed as in (C). The asterisk indicates protein degradation. (F) Mus81–Mms4 (5 g) or Mus81 (5 g) were mixed with GSH-beads in
the presence or absence of GST-Srs2783–998 (5 g). Beads were analyzed as in (C) above. The asterisk indicates protein degradation.
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down the interaction domain, we constructed and purified
five additional C-terminal truncations of Srs2, including
GST-Srs2783–1174, GST-Srs2783–998, GST-Srs2783–898, GST-
Srs2898–998 and GST-Srs2998–1174. These fragments of Srs2
were mixed with Mus81 and incubated with GSH-beads.
As shown in Figure 1E, only fragments GST-Srs2898–998 and
GST-Srs2998–1174 failed to bindMus81 protein, as confirmed
by Coomassie blue staining as well as western blot analysis.
Finally, we also tested the ability of Srs2 to interact with the
Mus81 subunit or the Mus81–Mms4 complex. When ap-
plied to GSH-beads, GST-Srs2 was able to retain both the
Mus81–Mms4 complex as well asMus81 alone (Figure 1F).
In summary, these experiments indicate a direct physical
interaction between Srs2 and the Mus81–Mms4 complex.
This interaction is mediated via Mus81 and the region re-
sponsible for this interaction within Srs2 protein resides in
aa 783–860.
The N-terminus of Mus81 is required for interaction with
Srs2
Since the Mus81 protein mediates the interaction with
Srs2, we aimed to determine the region of Mus81 pro-
tein required for this interaction. We therefore cloned, ex-
pressed and purified an N-terminal fragment of Mus81
(V5-His-Mus811–319) and tested its interaction with full-
length Srs2. A C-terminal fragment of Mus81 (V5-His-
Mus81319–632) was insoluble and could not be used for the
analysis. As shown in Figure 2A, the N-terminus of Mus81
was able to retain Srs2 on anti-V5 agarose beads. In addi-
tion, we compared the binding between full-length Mus81
and Mus811–319 and found that they both bind the Srs2
(Supplementary Figure S1A). Next, we tested the affinity of
Mus811–319 toward various N- and C-terminal truncations
of Srs2. Using the GSH-bead pull-down assay, an iden-
tical pattern of interaction was observed with full-length
Mus81. Similar results were obtained using bothCoomassie
blue staining and western blot analysis. The inability of the
Srs21–700 fragment to interact withMus811–319 confirms that
the interaction domain within Srs2 resides between aa 783–
860 (Figure 2B, C and D).
To map the interaction domain in greater details we
took advantage of the yeast two-hybrid assay. Here, the
Srs2783–1174 fragment was cloned into the pGADT7 vec-
tor and transformed into strain PJ69a. Next different trun-
cations of Mus81 (Mus811–155, Mus811–220, Mus811–245,
Mus811–288, Mus81138–632, Mus81290–632) cloned into pG-
BKT7were transformed into the PJ69 strain. Correspond-
ing strains weremated and grown on SD/-His/-Trp/-Leu to
select for positive interactions. As shown in Figure 2E and
Supplementary Figure S1B, the shortest Mus81 fragment
interacting with Srs2 contains the region 1–155. Taken to-
gether, we conclude that the Srs2-interacting domain is lo-
cated within the first 155 amino acids of Mus81.
Srs2 stimulates the activity of the Mus81–Mms4 endonucle-
ase
We (42) and others (47,48) have demonstrated that phys-
ical interactions with other proteins can lead to stimula-
tion ofMus81–Mms4 nuclease activity. Therefore, we asked
whether Srs2 had any effect on the endonuclease activity of
the Mus81–Mms4 complex. First, we used a 3′-flap DNA
structure which is one of theMus81–Mms4’s preferred sub-
strates and a relevant DNA intermediate during DNA re-
pair and replication (27). We titrated full-length Srs2 to-
gether with an amount of Mus81–Mms4 that cleaves∼10%
of the substrate (0.25 nM). Indeed, we observed robust stim-
ulation of the Mus81–Mms4 endonuclease activity by Srs2
(Figure 3A). In particular, the cleavage was stimulated ∼2-
fold by 5 nM, 4-fold by 10 nM and 8-fold when 80 nM of
Srs2 was added to the reaction (Figure 3B). This stimula-
tion did not change the cleavage pattern of Mus81–Mms4
as seen on denaturing PAGE (Supplementary Figure S1C).
In addition, we wished to test whether Srs2 was able
to target Mus81–Mms4 to the substrate. To this end, pre-
incubation of Srs2 with 3′-flap DNA substrate followed by
addition of Mus81–Mms4 resulted in 3- to 4-fold higher
stimulation of nuclease activity compared to a reaction in
which both proteins were added simultaneously (Figure 3C
andD). To further characterize the effect of Srs2 on the rate
ofMus81–Mms4 cleavage, we conducted time course exper-
iments. A sub-optimal amount of Mus81–Mms4 complex
(0.25 nM) was incubated either alone or with 10 nM Srs2
in the presence of 3′-flap DNA, and aliquots of the reaction
were withdrawn and analyzed over time. As shown in Fig-
ure 3E and F, in the presence of 10 nM Srs2 resulted in a
2-fold stimulation of 3′-flap cleavage in the first 10 min, and
amaximum of 6-fold stimulation at 50 min compared to the
Mus81–Mms4 reaction alone.
Next, we tested whether various truncation fragments of
Srs2 could also stimulateMus81–Mms4 activity. Increasing
concentrations of each fragment and full-length Srs2 pro-
tein were mixed together with the Mus81–Mms4 complex
(0.25 nM) and the 3′-flap structure. As expected, all Srs2
fragments that interacted with Mus81 in pull-down assays
were also able to stimulate Mus81–Mms4 nuclease activity.
In particular, the Srs21–898, Srs21–860 and Srs2783–1174 trunca-
tions containing region 783–860 of Srs2 were able to stimu-
late nuclease cleavage to the same extent as full-length Srs2
(Figure 3G and H). Although decreased, Srs2783–898 was
also able to significantly stimulate the Mus81–Mms4 com-
plex. Figure 3G summarizes the quantification of the indi-
vidual experiments. We also tested if Srs21–700 was able to
stimulate nuclease activity of Mus81–Mms4 since it failed
to interact. We observed only mild stimulation compared to
full-length Srs2 (Supplementary Figure S1D and E). Simi-
larly, the Srs2898–998 and Srs2998–1174 fragments showed very
mild stimulation of 3′-flap cleavage and only at the high-
est concentration used (Figure 3G). In addition we also cre-
ated an Srs2 mutant missing theMus81-interaction domain
(Srs2-783–860). However, this mutant had poor solubility
and lacked both Mus81–Mms4 stimulation and DNA heli-
case activity. The fact that these results were obtained de-
spite the fact that Srs2-783–860 contains all helicase do-
mains, suggested a potential misfolding or instability defect
(data not shown). For this reason, Srs2-783–860 was not
used for further analysis.
Srs2 possesses a ssDNA-dependent ATPase activity
(5,49). This activity fuels its translocation on ssDNA thus
allowing the unwinding of DNA as well as disassembly of
Rad51-ssDNA nucleoprotein filaments (8–9,49). The Srs2-
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Figure 2. Mapping of the Srs2 interaction withMus81. (A) Full-length Srs2 (5 g) was incubated in the absence or presence of Mus811–319 (5 g) and anti-
V5 agarose beads. Beads were washed, treated with SDS to elute bound proteins and fractions analyzed by Coomassie blue staining. The asterisk shows
protein contamination. (B) Srs21–898 (5 g, lanes 1–4) and Srs21–860 (lanes 5–6) were mixed with Mus811–319 (5 g) as indicated, followed by incubation
with anti-V5 agarose beads. Beads were treated as described above. (C) Srs21–700 (5 g) was incubated in the absence or presence of Mus811–319 (5 g)
and anti-V5 agarose beads. Beads were analyzed as described above. (D) Mus811–319 (5 g) was mixed with GSH-beads (lanes 1 and 2) or with GST-
Srs2783–1174, -Srs2783–998, -Srs2783–898, -Srs2898–998, or -Srs2998–1174 (5 g) and GSH-beads (lanes 3–12). The beads were treated as described above. (E) The
yeast two-hybrid interaction between Srs2 and Mus81 is mediated by the N-terminus of Mus81. Strain PJ69–4 containing indicated plasmids expressing
Srs2 fused to the GAL4 transcription activation domain and N-terminal regions of Mus81 (Mus811–155, Mus811–220 and Mus811–245) fused to the GAL4
DNA-binding domain were spotted as 10-fold serial dilutions on medium lacking tryptophan and leucine (-trp leu) or lacking tryptophan, leucine and
histidine (-trp leu his). The empty vector (pGADT7) was included as negative control.
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Figure 3. Srs2 stimulates Mus81–Mms4 nuclease activity. (A) Mus81–Mms4 (0.25 nM) and increasing amounts of Srs2 (5, 10, 20, 40 and 80 nM) were
first pre-incubated at 30◦C for 30 min followed by addition of 3‘-flap DNA substrate (7 nM) and incubation for 30 min at 37◦C prior to analysis by native
gel electrophoresis. (B) Quantification of the data in (A) with S.D. based on three independent experiments. (C) Srs2 targets Mus81–Mms4 complex for
cleavage. Srs2 (70 nM) was first pre-incubated with 3′-flap structure (6 nM) at 30◦C for 10 min followed by the addition of Mus81–Mms4 (0.25 nM) and
incubation for 2.5, 5, 7.5, 10 and 15 min at 30◦C. Corresponding aliquots were analyzed as in (A). (D)Quantification of the data in (C) from a minimum of
three independent experiments. (E)Mus81–Mms4 (0.25 nM) was incubated with 3‘-flap DNA (7 nM) in the absence or presence of Srs2 (10 nM) at 37◦C
for 10, 20, 30, 40 and 50 min. Aliquots of the reactions were taken at the indicated times and analyzed as in (A). (F) Quantification of the data in (E) with
S.D. based on three independent experiments. (G) Quantification of nuclease assays with various fragments of Srs2 with S.D. based on three independent
experiments. (H) Summary of interaction mapping by pull-down (PD) and nuclease assays (NA).
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K41R protein, which contains a mutation in the Walker A
domain that is responsible for the binding and hydrolysis of
ATP, is devoid of the above-mentioned functions (50). We
therefore next asked if thismutant is able to stimulate the en-
donuclease activity of the Mus81–Mms4 complex. For that
purpose we performed nuclease assays in the presence of the
increasing amounts of Srs2-K41R. As shown in the Supple-
mentary Figure S2A, Srs2-K41R protein is fully capable of
stimulating Mus81–Mms4 to the same extent as wild-type
Srs2. This indicates that the helicase activity of Srs2 is not
required for the stimulation of the Mus81–Mms4 complex.
To further support this conclusion, we tested the ability of
ATP- -S to potentiate the stimulatory effect of Srs2 on the
Mus81–Mms4 nuclease activity. However, ATP- -S had no
effect on the stimulation of Mus81–Mms4 by Srs2 (Supple-
mentary Figure S2B).
In summary, these data indicate that Srs2 is able to effi-
ciently stimulate the nuclease activity of Mus81–Mms4. We
conclude that the region 783–860 of Srs2 is required for both
Mus81 interaction and stimulation, and that this stimula-
tion is independent of Srs2 helicase/ATPase activity.
Stimulation of Mus81–Mms4 activity by Srs2 is species-
specific
Due to the evolutionary conservation of Mus81 protein, we
also tested the effect of Srs2 on the human MUS81 ho-
molog. First, we analyzed the ability of GST-Srs2783–998 to
interact with the human MUS81–EME1 complex. Using
a pull-down assay we observed MUS81–EME1 binding to
GSH-beads in the presence of a GST-Srs2 fragment (Sup-
plementary Figure S3A), which indicates that they physi-
cally interact. Using the same approach as above, we then
tested the effect of Srs2 onMUS81–EME1 nuclease activity.
However, Srs2 showed only limited enhancement of human
MUS81–EME1 activity compared to the robust stimulation
of yeast Mus81–Mms4 (Supplementary Figure S3B). This
indicates that despite the observed interaction, it is insuffi-
cient to stimulate MUS81–EME1 nuclease activity. To fur-
ther analyze the specificity of the stimulation, we also tested
the effect of Srs2 on another structure-specific nuclease, the
yeast Rad1–Rad10 complex. In contrast to Mus81–Mms4,
addition of Srs2 did not result in significant stimulation;
rather, we observed inhibition at higher Srs2 protein con-
centration (Supplementary Figure S3C). Similarly, we did
not observe stimulation of Mus81–Mms4 nuclease activity
by UvrD helicase, the bacterial homolog of Srs2 (Supple-
mentary Figure S3D), which confirms the specificity of Srs2
stimulation toward Mus81–Mms4.
Cleavage of D-loop, nicked HJ and fork structures is also
stimulated by Srs2
Mus81–Mms4 was previously shown to cleave a number
of DNA structures including those resembling replication
forks, nickedHolliday junctions (nHJ)D-loops and 3′-flaps,
whereas Y form and intact HJs were not efficiently cleaved
(25–27). We therefore wanted to test whether Srs2 could
also stimulate the endonuclease activity of Mus81–Mms4
on other substrates. As shown in Supplementary Figure S4,
Srs2 was efficient in stimulating Mus81–Mms4 cleavage of
D-loops, nHJ and fork DNA substrates to the same extent
as the 3′-flap DNA structure. On the other hand, we did not
observe any stimulation of Mus81–Mms4 nuclease activity
on Y form DNA (Supplementary Figure S4C), indicating
that Srs2 can modulate its activity but not influence the
structure selectivity of Mus81. Altogether, Srs2 is capable
of dramatically stimulating the nuclease activity of Mus81–
Mms4 on all substrates that this complex cleaves.
Effect of Mus81–Mms4 on the helicase activity of Srs2
The ability of Srs2 to stimulate the nuclease activity of the
Mus81–Mms4 complex prompted us to also test the effect
of Mus81 on Srs2 helicase activity. We pre-incubated Srs2
with increasing concentrations of Mus81–Mms4 complex
and monitored the unwinding of a 3′ overhang DNA struc-
ture. This substrate was chosen to avoid the nuclease activity
of the Mus81–Mms4 complex. As shown in Figure 4A, an
equimolar amount of Mus81–Mms4 results in almost 20%
inhibition of Srs2 helicase activity while 60% inhibition was
observed with 300 nM of theMus81–Mms4 complex. Since
the interaction between Srs2 andMus81–Mms4 is mediated
by Mus81 protein, we next tested whether Mus81 alone or
its N-terminal domain (Mus811–319) was also able to inhibit
Srs2 helicase activity. BothMus81 andMus811–319 inhibited
Srs2 helicase to the same extent as Mus81–Mms4 complex
(Figure 4B and C). To test the specificity of this inhibition,
we performed the same helicase assay with another Srs2-
interacting protein, Mre11. In contrast to Mus81, our re-
sults show that Mre11 was not able to block Srs2 helicase
activity (Figure 4D), confirming the specificity ofMus81 in-
hibition.
Rad51 inhibits cleavage by Mus81–Mms4 in a reaction sup-
pressed by Srs2
Since some of the structures that the Mus81–Mms4 com-
plex is able to cleave arise during recombination, we asked
whether the presence of Rad51 on such DNA will influence
the nuclease activity. Hence, we pre-incubated 3′-flap DNA
with increasing concentrations of Rad51 before addition of
Mus81–Mms4 complex. As shown in Figure 5A (lanes 4–
8), addition of Rad51 results in inhibition of Mus81–Mms4
nuclease activity. As expected, full inhibition was observed
approximately at saturation of the ssDNA part of the sub-
strate (3:1 nucleotide:monomer).
The ability of Srs2 to inhibit Rad51-mediated recombina-
tion by dismantling theRad51-ssDNApresynaptic filament
(8,9) prompted us to test whether this activity of Srs2 can
suppress Rad51-mediated inhibition of Mus81–Mms4 nu-
clease activity. Therefore, we pre-incubatedRad51 (600 nM)
with 3′-flap DNA followed by addition of Mus81–Mms4
(0.4 nM) and increasing concentrations of Srs2. While the
Rad51-filament formation inhibited the nuclease activity,
addition of Srs2 resulted in suppression of the Rad51-
mediated inhibition of Mus81–Mms4 activity (Figure 5B).
In particular, 5 nM Srs2 resulted in a 2-fold increase, and
20 nM Srs2 in a 5-fold increase of Mus81–Mms4 activity
compared to the inhibited reaction (Figure 5C). To deter-
mine whether the suppression of Rad51 inhibition was due
to its removal from the DNA by Srs2, we also tested the ef-
fect of the Srs2-K41Rmutant. As expected, Srs2-K41Rwas
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Figure 4. Mus81 blocks Srs2 helicase activity. (A) Srs2 (10 nM) was incubated with Mus81–Mms4 (12.5, 25, 50, 100, 200 and 300 nM) on ice for 10 min.
The 3′ overhang DNA (3 nM) was then added to the reactions and incubated for 10 min at 30◦C prior to analysis by native gel elctrophoresis. (B) Srs2
(10 nM) was indicated with either Mus81 or Mus811–319 fragment (12.5, 25, 50 and 100 nM) on ice. The 3′ overhang DNA (3 nM) was then added, and
the reactions were incubated for 10 min at 30◦C prior to gel analysis as above. (C) Quantification of the data in (B) with S.D. based on three independent
experiments. (D) Srs2 (10 nM) was incubated with increasing concentrations of Mre11 (12.5, 25, 50, 100, 200, 300 and 400 nM). After addition of substrate
DNA, the reactions were incubated for 10 min at 30◦C and analyzed as above.
not able to alleviate the effect of Rad51 on Mus81–Mms4
cleavage (Figure 5D), indicating that translocation of Srs2
and removal of Rad51 is required for this activity.
Genetic interactions betweenMUS81 and SRS2
Previous genetic data in budding and fission yeast suggests
that Srs2 and Mus81 act in the repair of single-stranded
gaps (18,46). To further assess the roles of the SRS2 and
MUS81 genes, we spotted dilutions of wild-type, single and
double deletion mutant strains onto agar plates containing
the ribonucleotide reductase inhibitor HU, the alkylating
agent MMS, the topoisomerase I poison CPT and the ra-
diomimetic chemical Zeocin.As shown inFigure 6, the dou-
blemutant wasmore sensitive to several of these agents than
either single mutant. The fact that this occurred at the low-
est concentrations of CPT, HU andMMS is consistent with
the idea that Mus81 and Srs2 act in separate parallel path-
ways for the processing of DNA damage induced by these
agents.
The synergistic effect observed in the double mutant
might be due to the multifunctional role of Srs2 in various
DNA repair pathways. Therefore, we also tested the srs2-
K41R mutant strain that is unable to remove Rad51 from
ssDNA (50). The srs2-K41R mus81 deletion strain showed
even greater sensitivity to CPT, HU and Zeocin compared
to the double deletion mutant. This suggests that the ability
to remove Rad51 and/or unwind recombination intermedi-
ates is also a Mus81-independent function.
Mus81 and Srs2 co-localize after DNA damage
Our biochemical data prompted us to test whether Srs2
and Mus81 co-localize in vivo with or without DNA dam-
age. Only ∼9% of the budded cells contained spontaneous
Mus81 foci and this formation was induced up to 20% by
treatment with CPT or Zeocin. In contrast, treatment of
the cells with HU had no significant effect on Mus81 fo-
cus formation (Figure 7). Accordingly, we observed signifi-
cant co-localization of Srs2 and Mus81 foci after treatment
with CPT, indicating a role for these proteins in the repair
of CPT-induced damage (Figure 7). The co-localization
of Mus81 and Srs2 after Zeocin treatment is also signif-
icant and was further enhanced by prolonged treatment
(Figure 7B), suggesting that Srs2 and Mus81 function to-
gether in the repair of chromosome damage. Analysis of
cell cycle stage shows culmination of Srs2 foci in S/G2, co-
localization foci with Mus81 in G2 and Mus81 foci alone
in G2/M phase (Figure 7C), suggesting that Srs2 might
be responsible for targeting Mus81 to sites of DNA repair.
However, Mus81 was fully proficient in focus formation in
the absence of Srs2 (Supplementary Figure S5). Further,
there was a statistically significant increase in spontaneous
Mus81 foci in the srs2 strain that was further increased
 at D
anm
arks N
aturO
G
 on M
ay 2, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
3636 Nucleic Acids Research, 2015, Vol. 43, No. 7
A B
C D
- -+
- - +
*
*
Mus81-Mms4
Rad51
1       2        3        4        5        6        7        8  
+++++ + + + + + + +---
-- -+ + ++ + + +
- - - -+
*
*
1        2        3       4        5       6        7        8       9      10
Srs2 (1-1174)
Rad51
Mus81-Mms4
+ + + + + + +---
- - -+ + + + + + +
+- - -
*
*
Srs2K41R
Rad51
Mus81-Mms4
1       2        3        4        5         6        7        8       9      10
0
10
20
30
40
50
60
0 5 10 15 20 25
%
 o
f D
N
A
 p
ro
du
ct
Srs2 concentration (nM)       
Srs2
Srs2K41R
-
Figure 5. Rad51 inhibitsMus81–Mms4 nuclease activity. (A)The 3′-flapDNA (7 nM)was incubatedwithRad51 (100, 200, 400, 600 and 800 nM) for 10min
at 37◦C.Mus81–Mms4 (0.4 nM) was then added to the mixture and the reaction was further incubated for 30min at 37◦C and analyzed as in Figure 3A. (B)
The reaction was assembled as described above with 600 nM Rad51 being pre-incubated with DNA. Mus81–Mms4 along with increasing concentrations
of Srs2 (5, 7.5, 10, 15 and 20 nM) were added to the reaction, incubated for additional 30 min at 37◦C and analyzed as above. (C) Quantification of the
data in (B) and (D) with S.D. based on three different experiments. (D) The 3′-flap DNA (7 nM) was incubated with Rad51 (600 nM) for 10 min at 37◦C
followed by addition of Mus81–Mms4 (0.4 nM) and Srs2-K41R (5, 7.5, 10, 15 and 20 nM). The reactions were incubated for 30 min at 37◦C and analyzed.
Figure 6. Genetic interactions between Srs2 and Mus81. DNA damage sensitivity of wild type (WT), mus81Δ, srs2Δ, srs2-K41R and the indicated double
mutants was assayed by spotting 10-fold serial dilutions of each strain on YPD plates and plates containing the indicated concentrations of CPT, HU,
MMS and Zeocin.
upon DNA damage. Such a result is consistent with the
idea that this strain accumulates toxic recombination inter-
mediates that are targets for Srs2-independent recruitment
of Mus81. Taken together, these results are consistent with
DNA damage-induced co-localization of Mus81 and Srs2.
The fact that Srs2 focus formation precedesMus81 suggests
that Srs2 could play a role in its regulation at the site of re-
pair.
DISCUSSION
The structure-specific endonuclease Mus81–Mms4/Eme1
has been shown to be involved in the maintenance of
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Figure 7. Localization of Srs2 and Mus81 after DNA damage. Cells expressing CFP-Srs2 and Mus81-YFP (ML733–12C) from their endogenous loci
were grown to exponential phase in synthetic complete medium supplemented with 100 g/ml adenine at 25◦C and subjected to fluorescence microscopy
before and after treatment with CPT, HU or Zeocin. (A) Srs2 and Mus81 co-localize at a subset of DNA lesions. Shown are images of representative cells
after CPT and Zeocin treatment. Arrowheads indicate foci. Scale bar, 3 m. (B) Quantification of Srs2 and Mus81 foci. For each experimental condition
300–600 cells were examined. Error bars indicate 95% confidence intervals. Significance relative to the untreated condition was determined by Fisher’s
exact test. NS, not significant. (C) Cell cycle distribution of Srs2 and Mus81 foci. For the CPT treated cells in panel B, cell cycle phase was evaluated by
measuring the bud-to-mother size ratio. Error bars represent 95% confidence intervals.
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genome integrity by processing replication, recombination
and repair intermediates (22,29,31,51–52). Mounting evi-
dence also points to multiple roles of Srs2 during DNA
replication and recombination (4). Despite the roles of Srs2
andMus81 in SDSA, and recent advances in understanding
their regulation, themolecular mechanism of these enzymes
remains unclear. Here, we demonstrate a direct physical in-
teraction between Srs2 and the Mus81–Mms4 complex in
vitro as well as their co-localization in vivo. We also show
that this association leads to a strong stimulation ofMus81–
Mms4 nuclease activity on a variety of substrates. Together,
these findings lead us propose a model where, despite their
independent roles, Srs2 andMus81 cooperate in the resolu-
tion of replication and recombination intermediates to en-
sure genome stability.
Several pieces of evidence support this idea. First, the
N-terminus of Mus81 mediates the direct physical inter-
action with Srs2, while the Mus81-interaction domain of
Srs2 is independent of its helicase domain and its Rad51-
and PCNA-interaction domains (39–40,50). This suggests
that there is a separate Mus81-interaction domain within
Srs2. The fact that full-length Srs2 showed lower binding
affinity for Mus81 than its N- and C-terminal truncations
suggests that the truncated proteins provide better access
to a Mus81-interaction domain located within the complex
structure of Srs2.
Second, the physical interaction of Srs2 with the Mus81–
Mms4 complex results in robust stimulation of its nucle-
ase activity. Kinetic results from the time course experi-
ment shows that the initial reaction rate is linear. Thus,
Henri–Michaelis–Menten kinetics could describe the en-
zymatic activity, in which the linearity of the reaction ve-
locity reflects a role for Srs2 in stabilizing active Mus81–
Mms4 on the substrate. Interestingly, neither ATP bind-
ing nor its hydrolysis by Srs2 is needed for Srs2 to stimu-
late nuclease activity (Supplementary Figure S2). A stim-
ulation of Mus81 activity was reported for yeast and hu-
man Rad54 proteins (42,47). However, the mechanisms of
stimulation are likely to be different, since the interaction
between Srs2 and Mus81 does not require ssDNA, as was
the case for the Rad54 interaction (42). This conclusion is
further supported by the fact that nuclease stimulation re-
quires a small fragment of Srs2 spanning residues 783–898
that does not bind DNA. However, we cannot exclude the
possibility that the ability of Srs2 to bind DNA may play a
role in stimulation of Mus81 nuclease activity (Figure 3G),
since larger fragments of Srs2 that bind DNA show an even
higher level of stimulation. In addition, while Rad54 stim-
ulation seems to be evolutionarily conserved, the Srs2 ac-
tivation is species-specific due to its inability to stimulate
human MUS81–EME1 complex.
Third, Srs2 is able to co-immunoprecipitate Mus81 and
it co-localizes with Mus81 in cells after DNA damage. The
in vivo interaction is also supported by expression profiles
of the proteins, which both increase in S phase and peak in
G2 (53,54). The shared expression profiles and the DNA
damage-induced co-localization of Srs2 and Mus81 sug-
gest that there is coordination and regulation of the in-
teraction. Indeed, Mus81 function in yeast is subject to
tight cell cycle-dependent control. During S phase, Mus81–
Mms4/Eme1 was shown to have low activity presumably to
prevent untimely cleavage of replication forks (55–57) since
premature activation of the Cdk1/Cdc5/Mus81 pathway
induces deleterious crossovers (55). However, in late G2/M
mitotic cells, it becomes activated by phosphorylation and
is able to cleave any remaining replication-dependent re-
combination intermediates (55–57). This mechanism both
prevents genome instability during replication and ensures
processing of late replication intermediates. This facilitates
proper chromosome segregation which is a know function
of the human MUS81 complex (58,59). Srs2 is also phos-
phorylated by Cdk1, and this modification, while not af-
fecting the anti-recombinase activity of Srs2, promotes its
pro-recombinational repair andwas proposed to target Srs2
to specific DNA structures (60). The idea that Srs2 targets
Mus81 to such structures via its interaction domain is sup-
ported by our in vitro experiments as well as the observation
that the Srs2 foci precede the Mus81 foci.
Fourth, the ability of Rad51 to inhibit the nuclease activ-
ity of Mus81–Mms4 must be specific given that another ss-
DNA binding protein (RPA) did not present an obstacle for
Mus81–Mms4 cleavage (Figure 5 and data not shown). This
inhibition was alleviated by Srs2 and its ability to translo-
cate on ssDNA and remove Rad51 (8,9). This conclusion is
supported by the fact that the helicase-dead Srs2 mutant,
while being able to stimulate Mus81, was not able to sup-
press the Rad51 inhibition (Figure 5 and Supplementary
Figure S2). This indicates that both activities, Rad51 re-
moval and stimulation of the nuclease, could be required for
proper processing by Srs2. Srs2 could remove Rad51 from
various structures including a displaced extended strand
to promote strand annealing, and stimulates the resolution
of structures that can be cleaved by Mus81–Mms4 (Fig-
ure 8). Indeed, a Rad51-independent activity of Srs2 was
previously shown to promote SDSA, as a truncation mu-
tant of Srs2, incapable of binding Rad51, reduced the non-
crossover rates, albeit to a lesser extent than an SRS2 null
mutant (61). In addition, DSB repair in a system that mon-
itors RAD51-independent events (i.e. break-induced repli-
cation (BIR) and single-strand annealing (SSA)) showed a
requirement for Srs2 to remove Rad51 from DNA in order
to allow downstream repair events (10).
Fifth, we found that Mus81 prevents Srs2 from unwind-
ing recombination/replication intermediates. This observa-
tion suggests that Srs2 and Mus81 might coordinate their
activities to control the unwinding of specific intermedi-
ates in order to stabilize substrates that can be resolved
by Mus81–Mms4. We note that the inhibition of unwind-
ing could arise from the sequestering of substrate DNA by
Mus81. However, another Srs2- and DNA-binding protein,
Mre11, did not affect the helicase activity of Srs2, indicat-
ing that the inhibition of Srs2 by Mus81–Mms4 is likely to
be specific.
Based on available data we propose a model for the role
of Srs2 and Mus81 in processing recombination intermedi-
ates (Figure 8). Previous studies have shown that the anti-
recombinase activity of Srs2 is responsible for channeling
lesions into the post-replication repair pathway by remov-
ing Rad51 protein from ssDNA (8–9,62). However, Srs2
also demonstrates pro-recombination activity (11,63). For
example, a role of Srs2 in promoting SDSA is supported
by the fact that depletion of Srs2 not only reduced DSB
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Figure 8. Model for Srs2 and Mus81–Mms4 in resolution of replication and recombination intermediates. Rad51 filament formation is promoted by
recombination mediators or disassembled by the action of Srs2. A stable Rad51 filament is able to search for a region of homology that results in the
formation of a D-loop structure. (A) The D-loop can be unwound by the action of Mph1 helicase or serve as a point for DNA repair extension. The
D-loop can alternatively be converted into a replication fork by the coordinated action of Srs2 plus Mus81–Mms4. Similarly Srs2 and Mus81–Mms4 can
process stalled replication forks leading to single ended breaks (SEB) that would require HR for repair. (B) Coordination between Srs2 andMus81–Mms4
would also be required to remove Rad51 from various structures including displaced extended strand to promote strand annealing and resolution of
structures that can further be cleaved by Mus81–Mms4. (C) In classical DSBR pathways Srs2 limits the second-end capture by regulating the length of
the extension in a SUMO-PCNA-dependent manner. The indicated subset of structures (nicked single or double Holliday junctions, nsHJ or ndHJ) can
alternatively be cleaved by Mus81–Mms4/Srs2 to ensure genomic stability.
repair efficiency and non-crossover events, but it also re-
sulted in a proportional increase in crossovers (10–11,64–
65). Based on Srs2’s biochemical activities, it was suggested
that Srs2 could promote SDSA by preventing second-end
capture (10) or by regulating strand elongation within a D-
loop structure (12). It was also shown that Srs2 could un-
wind the invading strand from the template DNA in an
oligo-based substrate (66). However, in the context of a
Rad51-catalyzed D-loop and following extension of the in-
vading strand, Srs2 is not able to displace the invading or
extended strand as efficiently as Mph1 (67,68). A recent
study byMitchel et al., that was able tomore specifically dis-
tinguish between HJ cleavage, dHJ dissolution and SDSA,
demonstrated thatwhile the absence of Srs2 had no effect on
crossovers, it resulted in decreased gap-repair efficiencies to-
getherwith early-appearing non-crossover events (61). They
proposed that Srs2 acts on D-loops, and nicked single or
double HJs. Shared genetic interactions in both S. cere-
visiae and Schizosaccharomyces pombe indicate that Srs2
andMus81 function in the same sub-pathway, but it was not
clear until now how the anti-recombinase activity of Srs2
could collaborate with Mus81 nuclease activity (18–19,46).
Our data provide evidence for the targeting of Mus81 by
Srs2 and for coordination of their activities in the processing
of various replication/recombination intermediates (Fig-
ure 8). This is in line with the ability of Srs2 to recognize
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a variety of branched DNA substrates containing a nick
that are also favorable substrates forMus81–Mms4 cleavage
(27,32,41–42). Finally, a small deletion within Srs2, corre-
sponding to the Mus81 interaction domain identified here,
was previously shown to be almost as detrimental to SDSA
as an srs2 deletion (69). This suggests that the region defined
by aa 783–860 of Srs2 is required for SDSA-mediated non-
crossovers. However, we note that in our hands this specific
deletion mutant is unstable and deficient not only for stim-
ulation of Mus81/Mms4 nuclease but also helicase activity.
Mus81/Srs2 activity within the SDSA pathway might also
be required when, as a result of over-synthesis, the invading
strand is excessively long to a degree where, after displace-
ment and annealing, 3′-flap DNA structures are formed
(Figure 8B). Alternatively, similar requirements for process-
ing might be needed for replication restart or when struc-
tures arise by annealing of strands with limited homology
(Figure 8A).
The hypersensitivity of both Srs2 andMus81 to CPT sug-
gests possible roles in the repair of DSBs as a consequence
of collapsed replication forks at strand nicks. This is dis-
tinct from normal PRR since mutants in the PRR pathway
are not CPT sensitive (70–73). The interaction of Srs2 with
SUMO-PCNA is a prerequisite for recruitment to replica-
tion forks (39,74–76), which places Srs2 in a temporal and
spatial position to mediate later steps in the repair (Fig-
ure 8A). In the case of fission yeast, Srs2 has been reported
to promote both fork restart and template exchange at ar-
rested forks (77,78). It has been proposed that this pathway
proceeds via a strand invasion/template switch mechanism
that uses an intact chromosome arm and generates aD-loop
that can be converted into a replisome (Figure 8A). Thus,
the coordinated activities of Srs2 and the Mus81 complex
might be required not only to process D-loops into replica-
tion forks, as proposed for Mus81 fork restart (79), but to
cleave stalled forks as reported for yeast and humanMus81
(22–23,31,80).
The notion that Srs2 and Mus81 have additional roles
that lie in separate pathways is obvious from the synergis-
tic increase in the DNA damage sensitivity of mus81 srs2
double mutants compared to single mutants (Figure 6). A
similar synergistic increase in CPT sensitivity was observed
in fission yeast (46). This is in line with other genetic results
showing only partial rescue of the mus81 sgs1 double mu-
tant by deletion of RAD51 compared to the more complete
rescue of the srs2 sgs1 strain (18). The increase in Mus81
foci observed in srs2 strains may reflect not only the for-
mation of toxic recombination intermediates that require
Mus81, but also a redundancy in targeting Mus81 to the
sites of DNA damage. Such a possibility is reminiscent of
Rad54 and BLM which were shown to stimulate and target
Mus81 activity (42,47,81). Interestingly, the srs2-K41Rmu-
tant sensitizes the mus81 strain to DNA damage even more
than srs2Δ.This suggests that the inability to removeRad51
and/or unwind deleterious intermediates is more toxic for
the cell than complete loss of Srs2 protein. Additional work
will be required to determine if this is caused by a non-
functional Srs2 protein blocking the processing of recom-
bination intermediates by enzymes such as Mus81.
Our data are also supported by the recent observation
that human FBH1 cooperates with MUS81 to promote en-
donucleolytic DNA cleavage following prolonged replica-
tion stress. This suggests that FBH1 helicase is required for
MUS81-dependent resolution of toxic intermediates (82).
The fact that FBH1 suppresses specific recombination de-
fects in the srs2 mutant (83) indicates that FBH1 is a func-
tional human homolog of Srs2 and suggests that the mech-
anism of cooperation with Mus81 is conserved. It is tempt-
ing to speculate that various translocases might recruit
Mus81 to corresponding intermediates that need to be pro-
cessed. As stated above, human and yeast RAD54 as well
as BLM have been reported to stimulate MUS81 activities
(42,47,81). However, Srs2 was not able to stimulate human
MUS81–EME1 indicating that this stimulation is species-
specific. Additional studies are required to determine which
of the Srs2 orthologuesmight possess this activity in human
cells.
In summary, our data help explain the roles of Srs2 and
Mus81 in the resolution of recombination/replication
intermediates. The uncoordinated regulation of
these proteins may lead to aberrant processing of
recombination/replication intermediates and contribute
to the chromosome instability associated with tumor cells
(84). This makes helicases and nucleases promising targets
for pharmacologic intervention in cancer therapy.
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